Walleye Trading’s Cellebrite CLBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$143K Buy
9,800
+9,000
+1,125% +$119K ﹤0.01% 3266
2026
Q1
$11K Sell
800
-6,400
-89% -$96.5K ﹤0.01% 3936
2025
Q4
$130K Sell
7,200
-2,300
-24% -$41.3K ﹤0.01% 3620
2025
Q3
$176K Buy
+9,500
New +$149K ﹤0.01% 3428
2025
Q1
– Sell
-1,100
Closed -$24.2K – 4133
2024
Q4
$24.2K Buy
+1,100
New +$21.2K ﹤0.01% 3929

Other funds holding CLBT

Walleye Trading's CLBT Position: Q2 2026 in Review

Walleye Trading sold out of Cellebrite (CLBT) in Q2 2026, closing a stake of 5,328 shares — an estimated $70.4K sold.

Walleye Trading first reported a position in CLBT in Q3 2024 and held it in 3 quarters. The position peaked at $112K in Q3 2024. 201 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

  • Walleye Trading reported no remaining Cellebrite position as of Q2 2026 after selling out during the quarter.
  • Walleye Trading sold 5,328 Cellebrite shares in Q2 2026, an estimated $70.4K.
  • Walleye Trading first reported a position in Cellebrite in Q3 2024 and held it in 3 quarters.
  • Walleye Trading's Cellebrite position peaked at $112K in Q3 2024.
  • 201 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on Walleye Trading's 13F filing for Q2 2026, filed 3 Aug 2026.